Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Up to 40% off top-quality waterproof jackets from The North Face, Rab, Patagonia, and more — this early Black Friday sale will save you from the November drizzle

    6. November 2026

    Access denied — Trend Hunter

    6. November 2026

    Access denied — Trend Hunter

    6. November 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Tegria Appoints Former TriZetto CEO Craig Mengert to Succeed Retiring Brian Cahill
    News

    Tegria Appoints Former TriZetto CEO Craig Mengert to Succeed Retiring Brian Cahill

    HealthradarBy Healthradar10. Juni 2026Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Tegria Appoints Former TriZetto CEO Craig Mengert to Succeed Retiring Brian Cahill
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Tegria Appoints Former TriZetto CEO Craig Mengert to Succeed Retiring Brian Cahill
    Craig Mengert, CEO at Tegria

    What You Should Know

    • Global healthcare consulting and services leader Tegria has announced the appointment of Craig Mengert as Chief Executive Officer, effective immediately.
    • Mengert succeeds Brian Cahill, who is retiring after a 47-year career and transitioning to serve as an independent director on Tegria’s Board of Directors.
    • The executive transition follows Tegria’s recent acquisition by Altaris, LLC, a healthcare-dedicated private equity firm focused on tech modernization and operational cost containment.
    • Mengert brings over 30 years of enterprise healthcare domain expertise, highlighted by his recent tenure as CEO of Cognizant’s TriZetto, where he managed a $1 billion P&L with 44% operating margins.
    • At TriZetto, Mengert spearheaded an aggressive agentic AI strategy, driving double-digit organic growth by embedding automated orchestration layers like the “TriZetto Assistant” to streamline complex prior authorizations and claims workflows.

    Leveraging a $1B Turnaround Blueprint and Payer-Provider Fluency

    Mengert’s appointment brings a highly specialized operational blueprint to Tegria. His more than 30 years of healthcare technology experience is highlighted by his recent tenure as CEO of TriZetto, a Cognizant subsidiary that manages some of the most critical transaction portfolios in the U.S. healthcare system. Inheriting an organization facing negative growth, Mengert engineered a major corporate turnaround, driving the company to sustained double-digit organic growth exceeding 14% year-over-year. Crucially, he managed a massive $1 billion P&L while maintaining operating margins over 44%, proving a rare ability to align cutting-edge innovation with strict financial discipline.

    A defining feature of Mengert’s strategy is his focus on “governance before autonomy”—responsibly deploying advanced technology within highly regulated clinical environments. At TriZetto, he championed the deep integration of artificial intelligence across all core platforms, pioneering agentic software solutions like the “TriZetto Assistant” to automate complex administrative workflows.

    Furthermore, his historical background—which began with over a decade managing core IT strategy and cost-reduction initiatives at Horizon BlueCross BlueShield of New Jersey—gives him an authentic understanding of the payer side of healthcare. For a comprehensive services firm like Tegria, which sits at the intersection of both provider and payer ecosystems, this dual-sided operational fluency is invaluable for breaking down traditional data barriers.

    “Tegria is a leading healthcare consulting firm delivering industry-recognized services,” Mengert stated. “The firm’s success is driven by a global team of more than 1,000 professionals who are dedicated to the provider and payer clients they serve. I am honored to step into the role of CEO to guide the firm’s next chapter.”

    Capitalizing on the Altaris Advantage to Eradicate Infrastructure Debt

    The timing of Mengert’s appointment aligns perfectly with Tegria’s recent acquisition by Altaris, LLC, a healthcare-dedicated private equity firm. Altaris doesn’t operate as a passive investor; instead, it takes controlling positions in healthcare enterprises positioned to strip out systemic waste, automate administrative overhead, and actively lower the total cost of care delivery.

    The backing of Altaris provides Tegria with a fortified balance sheet and the capital flexibility required to aggressively scale its AI implementation services, invest in deep clinical research, and pursue vertical acquisitions. Rather than forcing cash-strapped hospital networks or regional health plans into uncoordinated software investments, Tegria under Mengert’s leadership is positioned to help clients modernize legacy technology infrastructures, streamline core operations, and achieve measurable financial returns on investment (ROI). Outgoing CEO Brian Cahill will preserve this strategic continuity by remaining on the Board of Directors as an independent director, ensuring his extensive industry knowledge stays embedded within the firm’s forward-looking roadmap.



    Source link

    appoints Brian Cahill CEO Craig Mengert Retiring Succeed Tegria TriZetto
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleAGS Health Launches InnovationWorks™ Center of Excellence to Scale Revenue Cycle AI
    Next Article Bausch + Lomb to lay off employees in Missouri
    ekass777x
    Healthradar
    • Website

    Related Posts

    Ai

    Did Garmin just hint at higher prices next year? Behind the scenes, its CEO says pricing is ‚one of the things we can look at‘ as the RAM crisis begins to bite

    30. Oktober 2026
    News

    Reshoring prompts crucial decisions for medical device manufacturers

    26. Oktober 2026
    News

    Developers, not doctors, should be held accountable for generative AI medical devices, providers say

    23. Oktober 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 20251.076 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 20251.064 Views

    Luna ring review | TechRadar

    26. Dezember 2025234 Views

    The 4.5-star-rated Google Pixel Watch just fell back to its Black Friday price on Amazon

    26. Mai 2026232 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 20251.076 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 20251.064 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.